PROCA1
Protein PROCA1
Also known as: MGC39650, PRCA1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8NCQ7
- Gene
- PROCA1
- Ensembl
- ENSG00000167525
- Chromosome
- 17
- Canonical length
- 364 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nuclear membrane,Golgi apparatus
OverviewNCBI Gene
Enables cyclin binding activity. Predicted to be involved in arachidonate secretion and phospholipid metabolic process. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
364 residues, UniProt reviewed canonical sequence.
>Q8NCQ7|PROCA1
1 MWVRTTLTIE RWTKEKTEPK ARSWDEALSD VNRLPSWERG HLLAGVASST DVSTFSEGGD
61 CKEPDKCCWR HKQCTGHIIY PFASDCVRHS LHLHSVNHCN CNSRLKDSSE DSSSSRGAGP
121 TCSHVIESPC FELTPEEEHV ERFRYGWCKS YRPVSVAVIH HPLYHECGAD DLNEEEEEEE
181 EESKPPIPTQ VGPATASPDL GTSMATGTPD STAPITIWRS ESPTGKGQGS KVIKKVKKKK
241 EKEKDKEEMD EKAKLKKKAK KGQLTKKKSP VKLEPSPPDV SRSLSARQLA RMSESSPESR
301 EELESEDSYN GRGQGELSSE DIVESSSPRK RENTVQAKKT GAKPSQARKV NKRKSPPGSN
361 PNLSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PROCA1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.64
- Highest tissue expression
- 122 nTPM
Expression across tissuesHPA
Tissue
- testis: 122 nTPM
- spleen: 5.8 nTPM
- choroid plexus: 4.6 nTPM
- cerebellum: 4.5 nTPM
- kidney: 3.7 nTPM
- basal ganglia: 3.5 nTPM
Single-cell type
- late spermatids: 12,076 nCPM
- early spermatids: 1,860 nCPM
- late primary spermatocytes: 664 nCPM
- tuft cells: 58 nCPM
- early primary spermatocytes: 26 nCPM
- sertoli cells: 17 nCPM
Immune cell
- basophil: 5 nTPM
- eosinophil: 3.6 nTPM
- plasmacytoid DC: 2.5 nTPM
- memory B-cell: 2 nTPM
- intermediate monocyte: 1.7 nTPM
- non-classical monocyte: 1.3 nTPM
Brain region
- medulla oblongata: 3.4 nTPM
- cerebellum: 3.2 nTPM
- cerebral cortex: 3.1 nTPM
- midbrain: 2.6 nTPM
- pons: 2.4 nTPM
- white matter: 2.3 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.46
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.42
- DepMap mean gene effect
- -0.27
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PROCA1 as an antibody target. Whether an autoantibody or antibody against PROCA1 could matter depends on whether native PROCA1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PROCA1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PROCA1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...